Xeris Pharmaceuticals News

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W

Apr 11 16:11 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kong Garheng

Apr 1 17:48 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON JOHN

Apr 1 17:48 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON JOHN

Mar 18 17:36 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.

Mar 14 21:05 ET

Xeris Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 6 16:25 ET

Xeris Pharmaceuticals | 10-K: Annual report

Mar 6 16:15 ET

Xeris Pharmaceuticals | 8-K: XERIS BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND RECENT EVENTS

Mar 6 07:28 ET

Xeris Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.13%)

Feb 13 22:19 ET

Xeris Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Stonepine Capital Management, LLC(4.3%),Stonepine Capital, L.P(4.3%), etc.

Feb 13 16:37 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hecht Beth

Jan 31 17:08 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON KENNETH ERLAND

Jan 31 17:08 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shannon John Patrick Jr

Jan 31 17:08 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pieper Steven

Jan 31 17:08 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Edick Paul R

Jan 31 17:08 ET

Xeris Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)

Jan 26 16:26 ET

Xeris Pharmaceuticals | 8-K: Current report

Jan 4 00:00 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W

Nov 29, 2023 16:09 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HALKUFF DAWN

Nov 21, 2023 16:20 ET

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pieper Steven

Nov 21, 2023 16:16 ET